Comment on ‘the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer’
Abstract
To the EditorMa et al. present a provocative finding that high body mass index (BMI ≥24 kg/m2) is associated with superior overall survival (OS) in patients receiving first-line CDK4/6 inhibitors f...
Fields of Study & Subjects
Advanced Breast Cancer Therapies
Breast Cancer Treatment Studies
Cancer Risks and Factors
Publication details
- Journal / source
- Annals of Medicine
- Volume
- 58
- Issue
- 1
- Pages
- 2624893–2624893
- Publication date
- 15 February 2026
- Language
- EN